Benzodiazepines for treating small cell lung cancer
AssigneeGlaxoSmithKline LLC
InventorsOlena Barbash, Peter John Tummino
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a benzodiazepine compound, and its use in the treatment of cancer, particularly small cell lung cancer.
Claims3
A pharmaceutical composition comprising 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide or a pharmaceutically acceptable salt thereof for use in the treatment of small cell lung cancer.
A pharmaceutical composition according to claim 5 which is adapted for oral administration.
A combination pharmaceutical product comprising 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide or a pharmaceutically acceptable salt thereof together with one or more further therapeutically active agents suitable for use in the treatment of small cell lung cancer.
Dependencies are inferred from the claim text.